Bio-Rad Laboratories BIO
NYSE BIO
$368.86 -8.11 (-2.15%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Current Deferred Tax Assets (2009 - 2012)

Bio-Rad Laboratories' (BIO) quarterly Current Deferred Tax Assets came in at $57.8 million in Q4 2012, up 7.39% year-over-year from $53.8 million in Q1 2012, and up 7.39% quarter-over-quarter from $53.8 million in Q4 2011.

Analysis

Bio-Rad Laboratories (BIO) Current Deferred Tax Assets (2009 - 2012) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Current Deferred Tax Assets for 4 consecutive years, with $57.8 million the latest figure, recorded in Q4 2012.

  • On a quarterly basis, Current Deferred Tax Assets rose 7.39% year-over-year to $57.8 million in Q4 2012; TTM through Dec 2012 was $57.8 million, a 7.39% increase from a year earlier, with the FY2012 full-year figure at $57.8 million, up 7.39% from the prior year.
  • Current Deferred Tax Assets was $57.8 million for Q4 2012 at Bio-Rad Laboratories, up from $53.8 million in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $57.8 million in Q4 2012 and troughed at $43.1 million in Q4 2009.
  • A 4-year average of $50.7 million and a median of $50.9 million in 2010 frame the typical range for Current Deferred Tax Assets.
  • Across the five-year window, Current Deferred Tax Assets grew 11.99% in 2011 and gained 7.39% in 2012, its largest moves.
  • Over 4 years, Current Deferred Tax Assets stood at $43.1 million in 2009, then increased by 11.41% to $48.0 million in 2010, then gained by 11.99% to $53.8 million in 2011, then advanced by 7.39% to $57.8 million in 2012.
  • The last three Current Deferred Tax Assets figures came in at $57.8 million (Q4 2012), $53.8 million (Q4 2011), and $48.0 million (Q4 2010), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 57.75 Mn
Dec 31, 2011 53.78 Mn
Dec 31, 2010 48.02 Mn
Dec 31, 2009 43.10 Mn